Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides (BNP/Appetite)
Effects of Brain Natriuretic Peptide on Appetite-regulating Hormones and Endothelial-derived Peptides
研究概览
详细说明
This is a prospective, single blinded randomized, placebo-controlled, cross-over study, which will be conducted in ten healthy volunteers.
Each subject will participate in two study days/sessions, separated by a washout period of at least two weeks. The sessions will last approximately 4.5 hours. The subjects will come after having fasted overnight. Two intravenous cannulas will be placed in the right and left antecubital vein for infusions and blood sampling, respectively.
The subjects will receive intravenously once placebo and once 3.0 pmol/kg/min human active BNP (BNP-32) as a continuous intravenous infusion given during 4 hours (between time points 0 and 240 minutes). The order of study drugs will be randomized.
During the whole study session (lasting about 4.5 hours) the subject will remain fasted and confined to bed rest.
The changes in subjective ratings of hunger and satiety over time will be evaluated by 100 mm visual analog scales (VAS) half-hourly (between time points 0 and 240 minutes). Herewith the subjects rate their feeling of hunger (Hunger-VAS forms include the question: How hungry do you feel? Subjects are required to mark their feeling of hunger in a scale from 0 to 100 mm) and satiety (Satiety-VAS forms include the question: How satt do you feel? Subjects are required to mark their feeling of hunger in a scale from 0 to 100 mm).
Blood samples will be withdrawn twice at baseline (time points -5 minutes and 0 minutes) and hourly afterwards. Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of ghrelin, peptide YY, adiponectin, corticotropin, cortisol, adrenaline, noradrenaline, insulin, adrenomedullin, endothelin, copeptin, growth differentiation factor 15, BNP and atrial natriuretic peptide. All assays will be performed using commercial radioimmunoassays and enzyme-linked immunosorbent assays at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
The changes in VAS and hormone concentrations over time will be evaluated using repeated measurements analysis of variance (ANOVA) using the SPSS release 12.0.1 statistical software.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Vienna、奥地利、1090
- Medical University of Vienna
-
Vienna、奥地利、A-1090
- AKH, Medical University of Vienna
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Men aged 18 to 40 years
- written informed consent
- BMI < 25 kg/m2
- no concomitant diseases
- BNP level within the normal range
- Normal renal function (serum creatinine of less then 1.2 mg/dL and/or creatinin clearance greater than 80ml/min)
Exclusion Criteria:
- systolic blood pressure < 90 mmHg
- impaired glucose tolerance or diabetes mellitus
- hyperthyroidism, hypothyroidism
- hepatic, renal or cardiovascular diseases
- malignancies
- history of medical therapy within 3 weeks prior to enrolment into the study
- history of anaphylaxis
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
安慰剂比较:Placebo
0,9% NaCl administered as a continuous intravenous infusion during four hours.
|
0.9% NaCl administered as a continuous intravenous infusion during four hours
其他名称:
|
有源比较器:BNP
3.0 pmol/kg/min human active BNP administered as a continuous intravenous infusion during four hours.
|
3.0 pmol/kg/min human active BNP administered as a continuous intravenous infusion during four hours
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Changes in hunger scores on the visual analog scales (VAS) over time as compared to baseline (measured in mm)
大体时间:Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Subjects will be asked to rate their feeling of hunger in 100 mm VAS half-hourly (between time points 0 and 240 minutes). Hunger-VAS forms include the question: How hungry do you feel? Subjects are required to mark their feeling of hunger in a scale of 0 to 100 mm. |
Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Changes in satiety scores on the VAS over time as compared to baseline (measured in mm)
大体时间:Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Subjects will be asked to rate their feeling of satiety in 100 mm VAS half-hourly (between time points 0 and 240 minutes). Satiety-VAS forms include the question: How satt do you feel? Subjects are required to mark their feeling of satiety in a scale of 0 to 100 mm. |
Time points -5, 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes
|
Changes in plasma concentrations of ghrelin and acylated ghrelin over time as compared to baseline
大体时间:Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of ghrelin and acylated ghrelin.
All assays will be performed using commercial assay kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of peptide YY (PYY) over time as compared to baseline
大体时间:Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of PYY.
All PYY assays will be performed using commercial radioimmunoassay kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Changes in plasma concentrations of glucose and adiponectin over time as compared to baseline
大体时间:During two study sessions lasting 4 hours each and performed at least two weeks apart. Blood samples will be taken twice at baseline and then hourly afterwards (between time-points 0 minutes and 240 minutes)
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Glucose will be routinely measured in a certified laboratory (www.kimcl.at).
Samples for the measurement of adiponectin will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C.
All adiponectin assays will be performed using commercial kits at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
During two study sessions lasting 4 hours each and performed at least two weeks apart. Blood samples will be taken twice at baseline and then hourly afterwards (between time-points 0 minutes and 240 minutes)
|
Changes in plasma concentrations of cortisol, adrenaline and noradrenaline over time as compared to baseline
大体时间:Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of cortisol, adrenaline and noradrenaline.
These assays will be performed using commercial kits used for routine purposes at a certified laboratory (www.kimcl.at)
at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of B-type natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) over time as compared to baseline
大体时间:Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein in vacutainers containing heparin.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C for the later measurement of BNP and ANP.
These assays will be performed using commercial kits used for routine purposes at a certified laboratory at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Changes in plasma concentrations of endothelial derived factors (endothelin, adrenomedullin and growth differentiation factor 15) over time as compared to baseline
大体时间:Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
Blood samples will be withdrawn from an intravenous cannula placed circa 10 minutes before the start of the study in the left antecubital vein.
Samples will be immediately cooled on ice, centrifuged at 3000 rpm for 10 minutes and then stored at -20°C.
All assays for adrenomedullin, endothelin and growth differentiation factor 15 will be performed using commercial kits used for routine purposes at a certified laboratory at the very end of the study with samples belonging to (both study days) one subject being measured within one kit.
|
Timepoints -5, 0, 60, 120, 180 and 240 minutes.
|
合作者和调查者
调查人员
- 首席研究员:Anton Luger, MD、Medical University of Vienna
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- 060/2009
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
0.9% NaCl的临床试验
-
Alnylam Pharmaceuticals完全的淀粉样神经病 | 淀粉样神经病,家族性 | 遗传性淀粉样变性 | 转甲状腺素蛋白 (TTR) 介导的家族性淀粉样变性心肌病 (FAC) | 淀粉样变性,遗传性,转甲状腺素蛋白相关 | 家族性转甲状腺素蛋白心脏淀粉样变性美国, 法国, 意大利, 西班牙, 加拿大, 德国, 比利时, 瑞典, 英国
-
Ionis Pharmaceuticals, Inc.Akcea Therapeutics完全的